![]() Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. | ![]() Seed Health Seed Health is a microbial sciences company developing applications of bacteria to impact human and environmental health.
| ![]() IBL International IBL International is a company that develops, produces, and sells immunodiagnostic products. | Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | ![]() CANbridge Life Sciences CANbridge Life Sciences is a biopharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions. | |
Founding Date | Founding Date 2006 | Founding Date 2016 | Founding Date 1983 | Founding Date 1975 | Founding Date 2012 |
Type | Type Public | Type Private | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations New York, US HQ Waltham, US | Locations Venice, US HQ | Locations Hamburg, DE HQ Morrisville, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations CN HQ Hangzhou Shi, CN Cambridge, US |
Employees | Employees 10146% decrease | Employees 234 | Employees 502% decrease | Employees 332 | Employees 506% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) $63.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods $20.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $190.3m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit $42.3m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $156.4m (FY, 2018) | Gross profit N/A |
Net income | Net income ($32.9m) (FY, 2025) | Net income N/A | Net income N/A | Net income $40.5m (FY, 2018) | Net income N/A |
Operating ⚠ | |||||
Publications | Publications N/A | Publications 2.8 k (Dec, 2020) | Publications N/A | Publications 40 (Apr, 2020) | Publications N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 40m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 43m (over 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 40m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 224.1m |

Seed Health is a microbial sciences company developing applications of bacteria to impact human and environmental health.
View company
IBL International is a company that develops, produces, and sells immunodiagnostic products.
View companyBioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View company
CANbridge Life Sciences is a biopharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions.
View company